| 000 | 01067 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514200155.0 | ||
| 264 | 0 | _c20040923 | |
| 008 | 200409s 0 0 eng d | ||
| 022 | _a0250-7005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLans, T E | |
| 245 | 0 | 0 |
_aInvolvement of endothelial monocyte activating polypeptide II in tumor necrosis factor-alpha-based anti-cancer therapy. _h[electronic resource] |
| 260 |
_bAnticancer research _c |
||
| 300 |
_a2243-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCytokines _xbiosynthesis |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aRNA-Binding Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 700 | 1 | _aVan Horssen, R | |
| 700 | 1 | _aEggermont, A M M | |
| 700 | 1 | _aTen Hagen, T L M | |
| 773 | 0 |
_tAnticancer research _gvol. 24 _gno. 4 _gp. 2243-8 |
|
| 999 |
_c15027812 _d15027812 |
||